In gallbladder cancer, increased levels of CHIP expression are associated with a worse prognosis after surgery, whereas in pancreatic cancer and breast cancer, higher levels of CHIP expression are associated with higher survival [122,123,141]. This evidence concerns the gene STUB1 and pancreatic neoplasm.